June 5, 2007 (Toronto) — Exenatide can be an alternative to insulin glargine as an add-on treatment in patients with type 2 diabetes who are already receiving single-agent oral therapy, research ...

Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists. Initially approved by the FDA for the treatment of type 2 diabetes, ...